Previous Article | Next Article ![]()
Journal of Virology, September 1998, p. 7302-7309, Vol. 72, No. 9
Genzyme Corporation, Framingham,
Massachusetts 01701
Received 26 February 1998/Accepted 11 June 1998
Replication-defective adenovirus (Ad) vectors have been used for
gene transfer to the respiratory epithelium of experimental animals and
individuals with cystic fibrosis. Studies from several laboratories
have suggested that administration of first-generation Ad vectors
results only in transient gene expression in the lung, due at least in
part to destruction of vector-transduced cells by host cellular immune
responses directed against viral proteins and/or immunogenic transgene
products. We have constructed new Ad2-based, E1-deleted vectors
encoding a weakly immunogenic transgene, the human cystic fibrosis
transmembrane conductance regulator (hCFTR) under the control of the
cytomegalovirus enhancer-promoter. These vectors contain wild-type E2
and E4 regions. These new Ad/CFTR vectors were instilled into the
lungs of immunocompetent C57BL/6, BALB/c, and C3H mice. In vitro
cytotoxic T lymphocyte (CTL) analysis indicated the presence of
Ad-specific CTLs in treated mice. However, we were not able to
demonstrate a CTL response specific for hCFTR. Reverse transcriptase
PCR analysis demonstrated that hCFTR mRNA expression continued in all
three strains of mice for at least 70 days, the last time point
analyzed. The E3 region did not play a significant role in persistence
of the Ad/CFTR vectors in the mouse lung. Functional hCFTR
expression was also observed in the nasal epithelia of CF mutant mice.
These results suggest that long-term expression of hCFTR is possible in
the airway epithelia of immunocompetent mice without radical
modification of Ad vector and in spite of the presence of CTLs.
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Adenovirus-Mediated Persistent Cystic Fibrosis
Transmembrane Conductance Regulator Expression in Mouse Airway
Epithelium
*
Corresponding author. Mailing address: Genzyme
Corporation, One Mountain Rd., Framingham, MA 01701. Phone: (508)
872-8400. Fax: (508) 872-9080. E-mail: ascaria{at}genzyme.com.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»